Home ›
Organizations ›
BBG ADVANCED THERAPIES
BBG ADVANCED THERAPIES
TX · Healthcare · EIN 462216869
20
Executives Disclosed
$5.4M
Annual Revenue
$23.7M
Total Assets
1.8:1
Internal Pay Ratio
BBG ADVANCED THERAPIES has 20 executives with disclosed compensation. The highest-paid executive, Geoffrey Kindt (General Manager, Biomanufacturing (thru 11/02/2024)), received peak total compensation of $345,519. The sector average for Healthcare executives is $506K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Geoffrey Kindt | General Manager, Biomanufacturing (thru 11/02/2024) | $346K | $374K | 2024–2024 | 4.6x |
| Milton Masayuki Pollard | VP, GENCURE OPERATIONS (thru 07/09/2024) | $257K | $220K | 2022–2024 | 3.4x |
| Becky Cap | SVP COO, GENCURE (THRU 09/22) | $253K | $303K | 2016–2022 | 3.4x |
| Mari Lane Salmi | SR. DIRECTOR, PROCESS DEV & CELL THERAPIES | $244K | $244K | 2022–2024 | 3.3x |
| Rogelio Zamilpa | Executive Director, Biomanufacturing & Collab | $243K | $243K | 2018–2024 | 3.2x |
| Michael James Fiske | VP CELL MANUFACTURING | $218K | $218K | 2017–2019 | 2.9x |
| Pamela Brown Baer | SVP COO TTTS | $217K | $217K | 2018–2019 | 2.9x |
| Amanda Whitelonis | Principal Global Market Development (effective 11/03/2024) | $199K | $219K | 2024–2024 | 2.7x |
| Thomas William Johnson | VP SALES | $199K | $213K | 2017–2017 | 2.6x |
| Christie Elaine Malone | DIRECTOR, BUSINESS DEVELOPMENT | $197K | $197K | 2019–2022 | 2.6x |
| Alfredo E Cervera | DIRECTOR OF SALES | $184K | $184K | 2016–2017 | 2.5x |
| Miguel Garza | Director, Operations Biomanufacturing | $176K | $176K | 2024–2024 | 2.3x |
| Sean Allan Thompson | SR DIRECTOR BUS OPS & NEW PROD | $172K | $172K | 2018–2018 | 2.3x |
| Christopher Barnett | SENIOR DIRECTOR, PROC DEV & MF | $171K | $171K | 2019–2019 | 2.3x |
| Amanda Therese Whitelonis | DIRECTOR, PROGRAM MANAGEMENT | $165K | $165K | 2022–2022 | 2.2x |
| William G Elliott | DIRECTOR TISSUE CENTER DONOR S | $153K | $153K | 2018–2018 | 2x |
| Kathryn Ann Millar | SR SCIENTIFIC AND SALES SPECIA | $144K | $0 | 2022–2022 | 1.9x |
| Guillermo Burciaga Robles | SUPERVISOR, TISSUE RECOVERY | $143K | $0 | 2017–2017 | 1.9x |
| Jessica Ann Raley | DIRECTOR CATS | $136K | $0 | 2019–2019 | 1.8x |
| Richard Juarez | EXECUTIVE DIRECTOR, TISSUE CEN | $110K | $193K | 2018–2018 | 1.5x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 2 | $172K | $172K | $172K |
| 2017 | 5 | $214K | $244K | $641K |
| 2018 | 7 | $187K | $236K | $1.3M |
| 2019 | 7 | $206K | $237K | $1.0M |
| 2022 | 7 | $219K | $303K | $1.3M |
| 2024 | 6 | $246K | $374K | $1.5M |
Email Alerts
Get notified about BBG ADVANCED THERAPIES
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.